Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of a Single 150 mg Dose of Intravenous Fosaprepitant Dimeglumine for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Moderately Emetogenic Chemotherapy
Brief Summary: This study aims to demonstrate that, when given concomitantly with a 5-hydroxytryptamine 3 (5-HT3) antagonist and a corticosteroid, a single 150 mg intravenous (IV) dose of fosaprepitant given on Day 1 is superior to the control regimen of 5-HT3 antagonist and corticosteroid only, in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC).


Options:
A: Arm Label: metoclopramide; Type: ACTIVE_COMPARATOR; Interventions: Drug: metoclopramide | Arm Label: dexamethason; Type: ACTIVE_COMPARATOR; Interventions: Drug: dexamethason | Arm Label: palonosetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: palonosetron | Intervention Type: DRUG; Name: metoclopramide; Assigned to Arm(s): metoclopramide | Intervention Type: DRUG; Name: dexamethason; Assigned to Arm(s): dexamethason | Intervention Type: DRUG; Name: palonosetron; Assigned to Arm(s): palonosetron
B: Arm Label: Docetaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Docetaxel | Arm Label: Docetaxel/Casopitant; Type: EXPERIMENTAL; Interventions: Drug: Casopitant/Docetaxel | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Docetaxel | Intervention Type: DRUG; Name: Casopitant/Docetaxel; Assigned to Arm(s): Docetaxel/Casopitant
C: Arm Label: Aprepitant Regimen; Type: EXPERIMENTAL; Interventions: Drug: Aprepitant, Drug: Ondansetron, Drug: Dexamethasone, Drug: Ondansetron Placebo, Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride). | Arm Label: Control Regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aprepitant Placebo, Drug: Ondansetron, Drug: Dexamethasone, Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride). | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant Regimen | Intervention Type: DRUG; Name: Aprepitant Placebo; Assigned to Arm(s): Control Regimen | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Aprepitant Regimen, Control Regimen | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Aprepitant Regimen, Control Regimen | Intervention Type: DRUG; Name: Ondansetron Placebo; Assigned to Arm(s): Aprepitant Regimen | Intervention Type: DRUG; Name: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).; Assigned to Arm(s): Aprepitant Regimen, Control Regimen
D: Arm Label: Fosaprepitant Regimen; Type: EXPERIMENTAL; Interventions: Drug: Fosaprepitant dimeglumine, Drug: Dexamethasone, Drug: Ondansetron, Drug: Dexamethasone Placebo, Drug: Ondansetron Placebo, Drug: Rescue Therapy | Arm Label: Control Regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fosaprepitant Placebo, Drug: Dexamethasone, Drug: Ondansetron, Drug: Rescue Therapy | Intervention Type: DRUG; Name: Fosaprepitant dimeglumine; Assigned to Arm(s): Fosaprepitant Regimen | Intervention Type: DRUG; Name: Fosaprepitant Placebo; Assigned to Arm(s): Control Regimen | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Control Regimen, Fosaprepitant Regimen | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Control Regimen, Fosaprepitant Regimen | Intervention Type: DRUG; Name: Dexamethasone Placebo; Assigned to Arm(s): Fosaprepitant Regimen | Intervention Type: DRUG; Name: Ondansetron Placebo; Assigned to Arm(s): Fosaprepitant Regimen | Intervention Type: DRUG; Name: Rescue Therapy; Assigned to Arm(s): Control Regimen, Fosaprepitant Regimen

Answer: D